Introduction
The nervous and immune systems are not fully independent. In order to maintain homeostasis, both produce cytokines, neurotransmitters and/or express receptors that act upon important physiological functions (Gallowitsch-Puerta and Pavlov, 2007; Junger, 2011; Pena et al., 2011; Rosas-Ballina et al., 2011; Ulloa, 2013; Wang et al., 2004) . The vagus nerve system (VNS) exerts an essential role in the regulation of inflammation via releasing endogenous acetylcholine (ACh) in the parenchyma of innervated organs. Although predominantly expressed in neuronal tissues, several types of immune cells, including macrophages, also express nAChRα7 mRNA (AlSharari et al., 2013) , and reduction of inflammatory cytokine production often occurs following nAChRα7 macrophage signaling (Bernik et al., 2002) . Moreover, in vitro treatment of lipopolysaccharidestimulated human macrophages with ACh reduces production of pro-inflammatory cytokines (TNFα, IL-1β, IL-6, IL-18) but not of the anti-inflammatory cytokine IL-10, and direct in vivo VNS stimulation also prevented development of shock (Borovikova et al., 2000) . Likewise, ACh released from activate spleen T lymphocytes interact with nAChRα7 on macrophages present in the red pulp and marginal zone inhibiting TNFα production (Andersson and Tracey, 2012; Rosas-Ballina et al., 2011) and B cell antibody secretion (Andersson and Tracey, 2012) , but activating the release of the anti-inflammatory IL-10 cytokine from Th2 cells (Trakhtenberg and Goldberg, 2011) . The potential role of the cholinergic anti-inflammatory pathway via VNS and nAChRs activation has been demonstrated in various experimental models of septic peritonitis (Borovikova et al., 2000) ; ultraviolet experimentally injured skin (Osborne-Hereford et al., 2008) ; collagen-induced rheumatoid arthritis (van Maanen et al., 2009) , and more recently it was demonstrated that nAChRα7-dependent mechanisms and signaling are involved in the modulation of chronic inflammatory neuropathic pain (AlSharari et al., 2013) , and also neuroprotection under ischemic conditions by regulation of neuroinflammation and oxidative stress (Parada et al., 2013) .
Duchenne muscular dystrophy (DMD) is an X-linked progressive fatal myopathy caused by mutations in the gene encoding for the cytoskeletal protein dystrophin, which is important for organizing the membrane cytoskeleton, and aggregating ion channels and neurotransmitter receptors (Carlson, 1998; Hoffman et al., 1987) . Lack of dystrophin compromises the structural integrity of the cell membrane leading to aberrant intracellular signaling cascades that regulate both inflammatory and immune activities and contribute substantially to the physiopathology of muscular lesion (Evans et al., 2009; Lagrota-Candido et al., 2002) . Mdx mouse, the animal model of human DMD, develops a benign phenotype with a multi-staged disorder characterized by intense myonecrosis with scattered inflammatory infiltrate at 4 weeks (4 wks) of age followed by muscular regeneration (12 wks) and later persistent fibrosis (24 wks) (Collins and Morgan, 2003; Evans et al., 2009; Lagrota-Candido et al., 2002) . Our group observed a modulation of nAChRα7 expression at different stages of the mdx muscular dystrophy, and that nicotine treatment attenuated muscular inflammation and increased muscle regeneration (Leite et al., 2010) . This work aimed to provide additional insight on selective activation of nAChRα7 in the mdx muscular inflammation. For such purpose, we used the α7 KO mice and pharmacological manipulation (Parada et al., 2013) with PNU282987 and the nAChRα7 antagonist methyllycaconitine (MLA). This approach allowed us to determine a putative role of α7-mediated stimulation or blockade of endogenous cholinergic activation in the mdx muscular pathology.
Results

Selective nAChRα7 activation reduces serum and muscular inflammation in mdx mice
TNFα circulating levels were determined to verify a putative effect of nAChRα7 activation in mdx mice inflammation. For such purpose it was chosen a 7-daily treatment with PNU282987, a selective nAChRα7 agonist used at two different doses (0.3 and 1.0 mg/kg); the MLA antagonist (1.0 mg/kg), or both agonist and MLA at 1.0 mg/kg. Intraperitoneal treatment of mdx mice with low dose (0.3 mg/kg) PNU282987 reduced TNFα circulating levels (Fig. 1A) , and such effect was even more evident (2173.3%; po0.005) following treatment with 1.0 mg/ kg dose. Conversely, treatment of mdx mice with the competitive antagonist MLA at 1 mg/kg abolished the effect, being observed a slight increase on TNFα circulating levels comparing with vehicle-treated mouse. Furthermore, in combination with the agonist (1 mg/kg PNU282987 plus 1 mg/kg MLA) completely abolished the agonist effect, thus indicating a role for nAChRα7 in reducing the production of TNFα pro-inflammatory cytokine.
Next, we verified whether nAChRα7 activation could influence in the production and activity of MMPs, a family of endopeptidases which are important in normal physiological processes and skeletal tissue remodeling (Bani et al., 2008) . Increased MMP-9 activity in the serum reflects a process of active ongoing inflammation in several models (Khandoga et al., 2006; Maddahi et al., 2012; Schiøtz Thorud et al., 2005) . Treatment with 1 mg/kg PNU282987 caused a marked reduction (91716%; po0.005) of MMP-9 activity in the sera and also a significant reduction (54718%, po0.05) in the gastrocnemius muscle (Fig. 1B) . Treatment with MLA alone was not able to induce any alteration in the MMP-9 activity, but reversed PNU282987 agonist effect when administered concomitantly. PNU282987 treatment did not alter active MMP-2 in the serum (Fig. 1A) but caused a marked increase (170735% po0.05) in mdx gastrocnemius muscle compared with sham-control (vehicle) values. Such effect was reversed with combined (MLA plus PNU282987) treatment (Fig. 1B) , thus indicating a role for nAChRα7 activation in the mdx muscular tissue remodeling.
2.2.
Effect of nAChRα7 activation in bupivacaine bp-induced muscular lesion Increased skeletal muscle remodeling during acute stages of bp-induced inflammation is important for collagen degradation and facilitation of leukocyte migration with phagocytic properties for cell debris clearance (Kherif et al., 1999; Lagrota-Candido et al., 2010) . It was chosen a self-limited bp-induced muscular injury and applied 7-daily treatment b r a i n r e s e a r c h 1 5 7 3 ( 2 0 1 4 ) 2 7 -3 6 with drugs in nAChRα7 þ/þ and nAChRα7 À / À mice. It was observed significant reduction (33711%; po0.05) on MMP-9 activity, and a marked increase (81713%; po0.05) on active-MMP-2 activity in the wild-type nAChRα7 þ/þ ( Fig. 2A) . Conversely, treatment with the nAChRα7 selective agonist did not change MMP-9, pro-MMP-2 and active-MMP-2 activities in the nAChRα7 À / À mice (Fig. 2B ).
Selective nAChRα7 activation reduces muscle cell death
As selective nAChRα7 activation reduced muscular inflammation mediated by MMP-9 activity, we considered that PNU282987 could exert a protective effect on muscular cell membrane integrity. As an indicator for cytotoxicity damage it was used quantification of LDH release in the serum of mdx, and bp-induced muscle injury of nAChRα7 þ/þ and nAChRα7 À / À mice. Intraperitoneal PNU282987 (1 mg/kg) injection during 7 days reduced LDH activity in comparison to sham-control vehicle (71716%, po0.05). Treatment of mdx mice with 1 mg/kg MLA abolished PNU282987 effect and further increased LDH levels in comparison to mdx shamcontrol (vehicle). Furthermore, treatment of mdx mice with PNU282987 plus MLA both at 1 mg/kg was capable to partly reverse (po0.05) the protective effect afforded by the selective nAChRα7 activation (Fig. 3A) . Serum of nAChRα7 þ/þ mice with b r a i n r e s e a r c h 1 5 7 3 ( 2 0 1 4 ) 2 7 -3 6 bp-induced muscle injury obtained after treatment with selective nAChRα7 activation showed marked reduction (79730%, po0.05) on LDH activity compared to controlsham mice receiving vehicle. Combined drug treatment (PNU282987 plus MLA) abolished (po0.05) the effect. Conversely, drug treatment of nAChRα7 À / À KO mice with bp-induced muscular lesion did not change the pattern of LDH activity in the serum (Fig. 3B ). To establish a relation of nAChRα7 selective activation with reduced LDH serum levels and myoblast membrane integrity mice received Evans blue dye 24 h before sacrifice. Evans blue dye was almost excluded from mdx skeletal muscle fibers in mdx mice treated with 1.0 mg/kg PNU282987 which showed few red-fluorescent muscle fibers, an indication that treatment exerted a protective effect reducing myoblast necrosis (Fig. 3C ).
Selective nAChRα7 activation reduces mdx muscular lesion
Extravasation of inflammatory leukocytes from activated vascular endothelial cells into the site of injury is involved in the physiopathology of mdx muscular lesion by either 
promoting myonecrosis or muscular regeneration. Isolectin B4 (IB4) immunolabeling was used as histochemical marker to assess the influence of nAChRα7 selective activation on vascular endothelia of mdx mice. A slight IB4 immunolabeling was observed in the control wild-type nAChRα7 þ/þ muscular tissues. In contrast, after 7-days treatment with vehicle control-sham mdx mice showed an intense perivascular inflammatory infiltrate (Fig. 4A) . Treatment of mdx mice with 1.0 mg/kg PNU282987 reduced the area of perivascular inflammatory infiltrate and also the presence of IB4 positive active endothelia. Treatment with the competitive antagonist MLA reversed the antiinflammatory effect of PNU282987 (Fig. 4A) . Morphometric analysis confirmed that treatment of mdx mice with the selective nAChRα7 agonist PNU282987 reduced the area of inflammatory infiltrate (49713%, po0.005) and increased (34712%, po0.05) the percentage of regenerating myofibers characterized by strong basophilic and centrally located nuclei. Treatments did not cause significant changes ( Fig. 4B and C) in sirius red staining, used as a parameter of collagen deposition in the muscular microenvironment. Histological analysis of gastrocnemius muscle of nAChRα7 þ/þ mice with bp-induced muscular lesion showed a significant reduction of inflammatory infiltrate area (38%711%, po0.05) after selective nAChRα7 activation with PNU282987. In contrast, the experimentally injured muscle nAChRα7 À / À mice did not show any alteration after treatment (Fig. 4D ).
Discussion
Excessive inflammatory signaling is the underlying pathogenic mechanism leading to tissue damage in chronic inflammatory diseases, although activation of distinct anti-inflammatory pathways triggers the process of wound healing and tissue repair (Murray and Smale, 2012) . Indeed, activation of endogenous pathways responsible for regulating inflammation may restraint exacerbated immune response and activate diverse mechanisms that promote muscle regeneration in the mdx mouse, a model of inflammatory myopathy (Leite et al., 2010) . Data from various experimental models of inflammation point towards the nAChRα7 being crucial for cholinergic modulation of inflammation (AlSharari et al., 2013; Parada et al., 2013) . Although in vitro response to high nAChRα7 agonist concentrations rapidly desensitize the receptor for a long period (AlSharari et al., 2013) , in vivo treatment with nicotine was capable to significantly reduce mdx inflammatory lesion and increase muscle regeneration (Leite et al., 2010) . Indeed, the α7 subunit-containing nicotinic acetylcholine receptor (nAChRα7) is an essential component in the cholinergic anti-inflammatory pathway regulating the levels of TNF, high mobility group box 1 (HMGB1), and other cytokines during inflammation (Parrish et al., 2008; Pavlov and Tracey, 2012) .
To provide additional insight on the role of the α7 nAChR in mdx chronic muscular inflammation, we used the α7 KO mice and in vivo pharmacological manipulation with PNU282987, a highly selective nAChRα7 agonist that cause minor side effects than nicotine, and the MLA antagonist (Wang et al., 2004) . The spleen is a primary target for signals in the efferent pathway of the inflammatory reflex, because almost all TNF released systemically in the early phase of rodent endotoxemia originates in the spleen (Olofsson et al., 2012) . We observed that repeated administration of PNU282987 markedly reduced circulating levels of proinflammatory TNFα cytokine and MMP-9 activity in the serum, and also in mdx gastrocnemius muscle.
Matrix metalloproteases MMP-2, MMP-9 and also MMP-10 are directly involved in muscle plasticity being essential for skeletal muscle maintenance and regeneration in muscular dystrophies and sarcolemmal damage associated with mechanical injury (Bani et al., 2008; Bobadilla et al., 2014; Li et al., 2009; Rullman et al., 2007) . Since MMP-9 is upregulated at the height (3 wks-old) of the mdx myonecrosis (Bani et al., 2008; Li et al., 2009 ), a role for nAChRα7 in reducing mdx muscle inflammation was further confirmed with experiments showing MLA-induced reversion of the agonist stimulatory effect. Moreover, the nAChRα7 agonist was also capable to activate mdx muscle regeneration, as in vivo treatment with PNU282987 agonist also increased MMP-2 activity and the area with basophilic myoblasts characteristic of muscle regeneration. In addition, treatment did not reduce tissue inflammation in nAChRα7
À / À mice with bp-induced muscular lesion. This is an indication that selective nAChRα7 activation reduces the inflammatory signaling mediated by metalloprotease MMP-9 important for TNFα cleavage into 17-kDa mature form and the inflammatory pleiotropic actions of NFkB transcription factor signaling pathway. Interestingly NFkB activity in mdx muscle is localized in both dystrophic muscle and immune cells, and persistent NFkB signaling exacerbates production of proinflammatory mediators that promotes muscle necrosis and limits skeletal muscle fiber regeneration through inhibitory effect on muscle progenitor cells (Acharyya et al., 2007) . The abnormal clustering of acetylcholine receptors (AChR) on mdx skeletal muscle fibers compromises the formation of neuromuscular junction and functional integrity of skeletal muscles leading to massive infiltration of inflammatory cells, necrosis, and severe muscle degeneration characterized by increased leakage of cytosolic LDH and creatine kinase enzymes. Treatment with the nAChRα7 agonist PNU282987 reduced LDH release in the serum and myofiber necrosis of mdx and nAChRα7 þ/þ with bp-muscular lesion. Therefore, selective activation of nAChRα7 in both experimental models was capable to prevent development of muscular degeneration. Moreover, selective nAChRα7 activation also increased MMP-2 activity in skeletal muscles from both mdx and nAChRα7 þ/þ with bp-muscular lesion. This is an indication that nAChRα7 activation directly influences tissue remodeling by increasing muscular regeneration without inducing fibrosis and/or deposition of nonfunctional collagen. The hypothesis that nAChRα7 has a relevant involvement as a regulator of muscle inflammation and tissue remodeling is consistent because experimentally injured muscle nAChRα7 À /À mice did not show reduction on MMP-9 activity or modulation of active-MMP-2 after PNU282987 treatment. These data strongly suggest that metalloprotease balance is crucial for a switch between pro-inflammatory to tissue remodeling phenotype, and that nAChRα7 selective activation positively influence this phenomenon. Altogether the results indicate that nAChRα7 activation may be considered as a potential target for pharmacological strategies to reduce inflammation and activate mechanisms of muscular tissue remodeling.
Experimental procedure
Animal care
The animal use procedures were approved by the institutional animal care and used according to the guidance of Ethics Committee for Handling Research Animals of the Committee of Animal Experimentation from the Fluminense Federal University (CEUA-UFF, Brazil), and of the Medical School of Universidad Autónoma de Madrid (UAM-Spain).
Male mdx dystrophic and age-matched wild type nondystrophic mice (both C57BL/10 background) were maintained at the Cellular Pathology animal house facilities of the Institute of Biology, UFF, and male nAChRα7 knockout ( À/À ) and age-matched nAChRα7 wild type (þ/þ) mice (both C57BL/6 background) at Universidad Autónoma de Madrid.
Mice were kept at constant temperature (21 1C) with a light cycle of 12 h. Mdx and control mice were sacrificed in the period of inflammatory prevalence at 4 weeks, and nAChRα7 À / À and respective control mice at 6 weeks age.
4.2.
Inflammatory model -induction of muscular lesion nAChRα7 þ/þ and nAChRα7 À / À (KO) mice at 6 wks of age were anesthetized by intraperitoneal injection with ketamine (100 mg/Kg) and xylazine (10 mg/Kg). Muscular lesion was performed as previously described (Mussini et al., 1987) in the central region of gastrocnemius muscles. Ipsilateral muscle was injected with 60 mL 0.5% bupivacaine hydrochloride (bp) (Sigma-Aldrich, Spain), and the contralateral muscle (controlsham) with vehicle. À / À and nAChRα7 þ/þ mice with bp-induced muscular lesion were equally treated during 4 days. Groups were also treated with the nAChRα7 antagonist methyllycaconitine citrate ([1α, 4(S), 6β, 14α, 6, 14, 
In vivo pharmacological treatment
Quantification of TNFα by ELISA assay
Mice sera used for determination of TNFα levels were quantified in triplicate by commercial enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (PeproTech Inc., NJ, USA). Absorbance was assessed in a microplate spectrophotometer (Thermo Scientific™ Multiskan FC, USA) at wavelength 450 nm and also 650 nm correction filter after addition of 1% SDS stopping solution.
Gelatin zymography for detection of metalloprotease activity
Serum was immediately frozen in aliquots and preserved at À80 1C until use. Gastrocnemius muscles were removed, homogenized (TBS 1/10 w/v, 100 mM Tris-HCl pH 7.6, 200 mM NaCl, 100 mM CaCl 2 and 1% Triton X-100) then clarified by centrifugation at 15,000g for 10 min at 10 1C, and protein quantification determined by the Lowry method. Equal amounts of total protein were loaded (60 μg/lane for muscle; 20 μg/lane for serum) and metalloprotease activity determined by zymography as previously described (Kherif et al., 1999; Leite et al., 2010) . Gelatinase activity was visualized as unstained bands on a blue background representing areas of proteolysis. Metalloproteases are secreted in a latent form and require cleavage of a NH 2 terminus peptide for activation. Exposure of proenzymes to SDS during gel separation leads to activation without proteolytic cleavage (Talhouk et al., 1992) with appearance of bands corresponding to 100-kDa (MMP-9), 66-kDa (pre-pro-MMP-2) and 60-kDa (pro-MMP-2), and less frequently 55-kDa (active-MMP-2) (Kherif et al., 1999) . Semiquantitative analysis was performed by using image analysis software (Scion Image, NIH, Bethesda, Md., USA).
Histological staining and morphometric analysis
Gastrocnemius muscles were removed and fixed in formalinbuffered Millonig fixative (pH 7.2) for 24 h. Sections (10 μm thick) of tissue embedded in paraplast (Sigma, St. Louis, Mo., USA) were stained with hematoxylin and eosin and sirius red to analyze histological alterations and collagen deposition respectively. Degenerating and necrotic fibers were identified by homogeneous pale eosinophilic sarcoplasm, whereas regenerating fibers were characterized by strong basophilic and centrally-located nuclei. High-definition whole-area images of all cross sections from a single mouse at each time point were acquired from individual photomicrographs with a microdigital camera mounted on a Zeiss Axioplan microscope (Zeiss, Oberkochen, Germany) by using a 20 Â objective. Images were blended by using Adobe Photoshop CS3 Extended software. Total surface area, areas occupied by inflammatory infiltrate, regenerating myofibers and collagen deposition were determined with Image-Pro 4.5 (Media Cybernetics). For analysis of perivascular inflammatory infiltrate nearby blood vessel, sections were also stained for isolectin B4 (Isolectin GS-IB4 1:100; Vector, Burlingame, CA, USA), and its extension in each image demarcated by white dots. Results are expressed as percentage of total area in the cross-section.
Immunofluorescence
10 mm slices were washed with PBS and incubated for 1 h with blocking buffer (0.05% Triton X-100 in PBS, containing 5% normal goat serum (Crawford et al., 2000) . At the end of drug treatment, mice were sacrificed and muscles were removed, frozen in OCT (Tissue-Tek, Elkhard, IN,USA) embedding medium, and Evans blue uptake by individual fibers in 10 mm-thick frozen sections were fixed in cold acetone for image analysis in a Nikon Eclipse TE2000-U microscope (Olympus, Tokyo, Japan) with identical time exposure and image settings.
Quantitative and statistical analysis
Gelatin zymograms, histological staining and morphometry were analyzed using Scion Image for Windows software (Scion Corporation, National Institutes of Health; Bethesda, MD). GraphPad Prism 5 (GraphPad software Inc.) was used to calculate mean and standard errors. One-way ANOVA and unpaired t test were applied to obtain statistical significance of means. Differences were considered to be statistically significant at the 0.05 level of confidence. -2010-18837 to LG) and CEAL-Santander. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.
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